Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-02 23:28 | 2020-10-02 | FGNA | OppFi Inc. | SWETS LARRY G JR | Director, Officer, 10% owner - Chief Executive Officer | Finance Services | BUY | $10.00 | 462,500 | $4,625,000 | 462,500 | +100.0% |
| 2020-10-02 23:27 | 2020-10-02 | FGNA | OppFi Inc. | MOGLIA JOSEPH H | Director, Officer, 10% owner - Chairman | Finance Services | BUY | $10.00 | 462,500 | $4,625,000 | 462,500 | +100.0% |
| 2020-10-03 00:00 | 2020-09-30 | UEPS | LESAKA TECHNOLOGIES INC | Value Capital Partners (Pty) Ltd | 10% owner | Functions Related To Depository Banking, NEC | BUY | $3.44 | 350,024 | $1,204,818 | 10,134,056 | +3.6% |
| 2020-10-02 23:53 | 2020-09-30 | UEPS | LESAKA TECHNOLOGIES INC | Ball Antony C | Director | Functions Related To Depository Banking, NEC | BUY | $3.44 | 350,024 | $1,204,818 | 10,134,056 | +3.6% |
| 2020-10-01 23:24 | 2020-09-30 | N/A | N/A | Owl Rock Feeder FIC BDC III LLC | 10% owner | Other | BUY | $14.15 | 141,456 | $2,001,602 | 711,080 | +24.8% |
| 2020-10-01 23:23 | 2020-09-30 | N/A | N/A | Packer Craig | Director, Officer - CEO and President | Other | BUY | $14.15 | 141,456 | $2,001,602 | 711,080 | +24.8% |
| 2020-10-01 23:23 | 2020-09-30 | N/A | N/A | Kirshenbaum Alan | Director, Officer - COO | Other | BUY | $14.15 | 141,456 | $2,001,602 | 711,080 | +24.8% |
| 2020-10-01 22:20 | 2020-04-07 | SOBR | SOBR Safe, Inc. | Bennington Charles Warren | Director, Officer - Secretary | Periodicals: Publishing or Publishing & Printing | BUY | $9,656.03 | 6,832 | $65,969,997 | 457,958 | +1.5% |
| 2020-10-01 23:23 | 2020-09-30 | N/A | N/A | Ostrover Douglas I | Director | Other | BUY | $14.15 | 141,456 | $2,001,602 | 711,080 | +24.8% |
| 2020-10-01 23:33 | 2020-10-01 | IEP | ICAHN ENTERPRISES L.P. | ICAHN BRETT | Director | Petroleum Refining | BUY | $49.32 | 202,758 | $10,000,025 | 202,758 | +100.0% |
| 2020-10-01 23:12 | 2020-09-29 | PSTI | Pluri Inc. | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.16 | 199,129 | $2,024,126 | 3,987,589 | +5.3% |
| 2020-10-01 23:23 | 2020-09-30 | N/A | N/A | LIPSCHULTZ MARC S | 10% owner | Other | BUY | $14.15 | 141,456 | $2,001,602 | 711,080 | +24.8% |
| 2020-10-02 01:30 | 2020-09-29 | GRAY | CalciMedica, Inc. | Clarus Lifesciences III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 250,000 | $4,000,000 | 1,930,395 | +14.9% |
| 2020-10-02 00:01 | 2020-09-30 | EPD | ENTERPRISE PRODUCTS PARTNERS L.P. | WILLIAMS RANDA DUNCAN | Director, 10% owner | Natural Gas Transmission | BUY | $1,000.00 | 15,000 | $15,000,000 | 15,000 | +100.0% |
| 2020-10-02 00:36 | 2020-09-29 | GRAY | CalciMedica, Inc. | Flynn James E | 10% owner, Other | Pharmaceutical Preparations | BUY | $16.00 | 1,562,500 | $25,000,000 | 1,853,967 | +536.1% |
| 2020-10-01 00:20 | 2020-09-28 | N/A | Morgan Stanley Direct Lending Fund | MS Credit Partners Holdings Inc. | 10% owner | Other | BUY | $19.97 | 295,390 | $5,898,946 | 1,658,211 | +21.7% |
| 2020-10-01 02:52 | 2020-09-25 | PRLD | Prelude Therapeutics Inc | Bonita David P | Director, 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 1,236,800 | $23,499,200 | 917,412 | +100.0% |
| 2020-09-30 23:36 | 2020-09-28 | ODT | N/A | Davis Aaron I. | Director, 10% owner | Other | BUY | $13.63 | 215,200 | $2,932,165 | 5,207,086 | +4.3% |
| 2020-09-30 20:33 | 2020-09-28 | JFR | NUVEEN FLOATING RATE INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $8.30 | 375,793 | $3,119,082 | 6,627,116 | +6.0% |
| 2020-09-30 23:01 | 2020-09-28 | ODT | N/A | TANG KEVIN C | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $13.13 | 110,882 | $1,456,413 | 15,238,782 | +0.7% |
| 2020-10-01 01:37 | 2020-09-29 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director, 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 1,578,947 | $29,999,993 | 9,247,763 | +20.6% |
| 2020-09-30 23:31 | 2020-09-28 | ODT | N/A | Boxer Capital, LLC | Director, 10% owner | Other | BUY | $13.63 | 215,200 | $2,932,165 | 5,207,086 | +4.3% |
| 2020-09-29 19:15 | 2020-06-30 | CLNH | Nutex Health Inc. | Margolin Jacob | Director | Services-Business Services, NEC | BUY | $163,671.60 | 259,380 | $42,453,140,801 | 574,998 | +82.2% |
| 2020-09-29 23:38 | 2020-09-25 | PMVP | PMV Pharmaceuticals, Inc. | Thompson Peter A. | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 950,000 | $17,100,000 | 475,000 | +100.0% |
| 2020-09-29 23:30 | 2020-09-29 | PMVP | PMV Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 950,000 | $17,100,000 | 1,710,265 | +125.0% |
| 2020-09-29 23:43 | 2020-09-25 | CLR | N/A | Hamm Harold | Director, Officer, 10% owner - Executive Chairman | Other | BUY | $12.68 | 769,235 | $9,750,438 | 13,062,904 | +6.3% |
| 2020-09-30 03:10 | 2020-09-25 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 1,236,800 | $23,499,200 | 917,412 | +100.0% |
| 2020-09-29 23:41 | 2020-09-25 | GRAY | CalciMedica, Inc. | ORBIMED ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 562,500 | $9,000,000 | 562,500 | +100.0% |
| 2020-09-29 23:39 | 2020-09-25 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 950,000 | $17,100,000 | 475,000 | +100.0% |
| 2020-09-29 23:40 | 2020-09-25 | PMVP | PMV Pharmaceuticals, Inc. | Boxer Capital, LLC | Other | Pharmaceutical Preparations | BUY | $18.00 | 950,000 | $17,100,000 | 950,000 | +100.0% |
| 2020-09-28 17:10 | 2020-09-25 | BCPL | N/A | Forethought Life Insurance Co | 10% owner | Other | BUY | $24.93 | 64,180 | $1,600,000 | 402,516 | +19.0% |
| 2020-09-29 03:54 | 2020-09-24 | BCAT | BlackRock Capital Allocation Term Trust | Rieder Richard M | Other | Other | BUY | $20.00 | 100,000 | $2,000,000 | 100,000 | +100.0% |
| 2020-09-28 15:17 | 2020-09-24 | JFR | NUVEEN FLOATING RATE INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $8.28 | 198,879 | $1,646,539 | 6,251,323 | +3.3% |
| 2020-09-25 22:30 | 2020-09-25 | LSF | Laird Superfood, Inc. | Danone Manifesto Ventures, PBC | 10% owner | Food and Kindred Products | BUY | $22.00 | 90,910 | $2,000,020 | 857,194 | +11.9% |
| 2020-09-26 00:15 | 2020-09-24 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $16.87 | 300,000 | $5,061,000 | 2,408,472 | +14.2% |
| 2020-09-26 01:02 | 2020-09-25 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $56.65 | 48,125 | $2,726,180 | 11,324,937 | +0.4% |
| 2020-09-24 20:43 | 2020-09-22 | JFR | NUVEEN FLOATING RATE INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $8.34 | 301,369 | $2,514,231 | 6,052,444 | +5.2% |
| 2020-09-25 02:30 | 2020-09-22 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $51.71 | 203,047 | $10,498,586 | 11,280,001 | +1.8% |
| 2020-09-24 02:09 | 2020-09-21 | DYN | Dyne Therapeutics, Inc. | Logos Global Management LP | 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 700,000 | $13,300,000 | 1,504,392 | +87.0% |
| 2020-09-24 02:11 | 2020-09-21 | DYN | Dyne Therapeutics, Inc. | VV Manager II, LLC | 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 815,000 | $15,485,000 | 79,921 | +100.0% |
| 2020-09-24 01:55 | 2020-09-21 | DYN | Dyne Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 660,000 | $12,540,000 | 2,805,045 | +30.8% |
| 2020-09-23 23:44 | 2020-09-21 | SREV | N/A | Edenbrook Capital, LLC | 10% owner | Other | BUY | $1.36 | 1,631,300 | $2,222,809 | 13,611,126 | +13.6% |
| 2020-09-23 23:18 | 2020-09-21 | TA | N/A | PORTNOY ADAM D. | Director | Other | BUY | $21.57 | 104,738 | $2,259,199 | 621,853 | +20.3% |
| 2020-09-23 23:22 | 2020-09-21 | TRTX | TPG RE Finance Trust, Inc. | TPG Group Holdings (SBS) Advisors, Inc. | 10% owner | Real Estate Investment Trusts | BUY | $8.91 | 128,430 | $1,143,900 | 7,181,442 | +1.8% |
| 2020-09-24 02:07 | 2020-09-21 | ALRT | N/A | Chan Sidney | Director, Officer, 10% owner - CEO | Other | BUY | $0.05 | 240,000,000 | $12,000,000 | 383,498,482 | +167.2% |
| 2020-09-23 00:45 | 2020-09-18 | STEP | StepStone Group Inc. | Keck Thomas | Director, Other | Investment Advice | BUY | $18.00 | 55,750 | $1,003,500 | 55,750 | +100.0% |
| 2020-09-23 03:47 | 2020-09-18 | SNOW | Snowflake Inc. | ICONIQ Strategic Partners III, L.P. | 10% owner | Services-Prepackaged Software | BUY | $120.00 | 420,007 | $50,402,100 | 7 | +100.0% |
| 2020-09-23 00:43 | 2020-09-18 | MTCR | N/A | Chang Carmen | 10% owner | Other | BUY | $13.00 | 769,230 | $9,999,990 | 3,060,527 | +33.6% |
| 2020-09-23 00:40 | 2020-09-18 | MTCR | N/A | New Enterprise Associates 16, L.P. | 10% owner | Other | BUY | $13.00 | 769,230 | $9,999,990 | 3,060,527 | +33.6% |
| 2020-09-23 00:44 | 2020-09-18 | MTCR | N/A | Makhzoumi Mohamad | 10% owner | Other | BUY | $13.00 | 769,230 | $9,999,990 | 3,060,527 | +33.6% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.